===============================================================================
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
November 6, 2006
Diomed Holdings, Inc.
Delaware 000-32045 84-1480636
(State or other jurisdiction of (Commission File Number) (IRS Employer
incorporation) Identification No.)
1 Dundee Park
Andover, MA 01810
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code: (978-475-7771)
Item 7.01 Regulation FD Disclosure
On November 6, 2006, Diomed Holdings, Inc. issued a press release announcing
that the court presiding over Diomed's lawsuit alleging infringement by
AngioDynamics, Inc. and Vascular Solutions, Inc. of Diomed's U.S. Patent No.
6,398,777 has scheduled a hearing on December 8, 2006. The hearing is for
purposes of establishing a trial date in the patent infringement litigation. A
copy of this press release is attached as Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits
99.1 Press Release Issued November 6, 2006
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Diomed Holdings, Inc.
(Registrant)
Date: November 6, 2006 By: /s/ DAVID B. SWANK
---------------------
Name: David B. Swank
Title: Chief Financial Officer
List of Exhibits:
99.1 Press Release Issued November 6, 2006